Sutton Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-162
| Closed | -$6.26K | – | 1349 |
|
|
2022
Q4 | $6.26K | Sell |
162
-517
| -76% | -$20K | ﹤0.01% | 1066 |
|
|
2022
Q3 | $36.1K | Sell |
679
-2
| -0.3% | -$106 | 0.01% | 465 |
|
|
2022
Q2 | $39.7K | Sell |
681
-132
| -16% | -$7.7K | 0.02% | 443 |
|
|
2022
Q1 | $62K | Buy |
813
+132
| +19% | +$10.1K | 0.02% | 348 |
|
|
2021
Q4 | $41K | Buy |
681
+90
| +15% | +$5.42K | 0.01% | 482 |
|
|
2021
Q3 | $33.1K | Buy |
591
+393
| +198% | +$22K | 0.01% | 524 |
|
|
2021
Q2 | $12K | Sell |
198
-391
| -66% | -$23.7K | ﹤0.01% | 855 |
|
|
2021
Q1 | $41.3K | Buy |
589
+391
| +197% | +$27.4K | 0.02% | 443 |
|
|
2020
Q4 | $11.8K | Sell |
198
-226
| -53% | -$13.5K | 0.01% | 766 |
|
|
2020
Q3 | $25.5K | Buy |
424
+295
| +229% | +$17.7K | 0.01% | 477 |
|
|
2020
Q2 | $6.77K | Sell |
129
-2
| -2% | -$105 | ﹤0.01% | 800 |
|
|
2020
Q1 | $4.39K | Sell |
131
-341
| -72% | -$11.4K | ﹤0.01% | 856 |
|
|
2019
Q4 | $21.4K | Buy |
+472
| New | +$21.4K | 0.01% | 580 |
|